Expert opinion on drug delivery

Keyphrases

Publications

volume 21, number 4, 2024

Gholam Hossein Darya, Omid Zare, Hamid Reza Karbalaei-Heidari, Sedighe Zeinali, Heather Sheardown, Banafsheh Rastegari
Enzyme-responsive mannose-grafted magnetic nanoparticles for breast and liver cancer therapy and tumor-associated macrophage immunomodulation. Expert opinion on drug delivery 21 (4) (2024)
Hanhee Cho, Kwangmeyung Kim
Multi-functional nanomedicines for combinational cancer immunotherapy that transform cold tumors to hot tumors. Expert opinion on drug delivery 21 (4) (2024)
Flávia Sousa
Emerging cytokine delivery with nanomedicine for brain cancer treatment. Expert opinion on drug delivery 21 (4) (2024)
Sandra Aulia Mardikasari, Gábor Katona, Bence Sipos, Ildikó Csóka
Essential considerations towards development of effective nasal antibiotic formulation: features, strategies, and future directions. Expert opinion on drug delivery 21 (4) (2024)
Denzel Ryan D Cruz, Avery Zheng, Tilahun Ayane Debele, Peter J Larson, Gregory R Dion, Yoonjee C Park
Drug delivery systems for wound healing treatment of upper airway injury. Expert opinion on drug delivery 21 (4) (2024)
Carsten Ehrhardt
Aerosol delivery in interstitial lung diseases - breakthrough or lost cause? Expert opinion on drug delivery 21 (4) (2024)
Cristina Yus, Enrique Gámez, Manuel Arruebo
Expert opinion on antimicrobial therapies: is there enough scientific evidence to state that targeted therapies outperform non-targeted ones? Expert opinion on drug delivery 21 (4) (2024)
Denzel Ryan D Cruz, Avery Zheng, Tilahun Ayane Debele, Peter J Larson, Gregory R Dion, Yoonjee C Park
Drug delivery systems for wound healing treatment of upper airway injury. Expert opinion on drug delivery 21 (4) (2024)

volume 21, number 5, 2024

Laurie Brunet-Manquat, Anne Combedazou, Bomby Ahuja, Alice Maden, Claire Ramus, Tatsiana Mardovina, Cécile Frolet
Pre-ANDA strategy and Human Factors activities to de-risk pharmaceutical companies ANDA submission of drug-device combination products: case study of a formative Comparative Use Human Factors study. Expert opinion on drug delivery 21 (5) (2024)
Neeraj Vij
Precision nanoparticles for prognosis-based early intervention of COPD-emphysema. Expert opinion on drug delivery 21 (5) (2024)
Iordana Neamtu, Alina Ghilan, Alina Gabriela Rusu, Loredana Elena Nita, Vlad Mihai Chiriac, Aurica P Chiriac
Design and applications of polymer-like peptides in biomedical nanogels. Expert opinion on drug delivery 21 (5) (2024)
Benoit Hosten, Sébastien Goutal, Sarah Leterrier, Cassandre Corvo, Louise Breuil, Olivier Barret, Simon Specklin, Charles Truillet, Nicolas Tournier
Brain delivery enabled by transient blood-brain barrier disruption induced by regadenoson: a PET imaging study. Expert opinion on drug delivery 21 (5) (2024)
Kristiina M Huttunen
Improving drug delivery to the brain: the prodrug approach. Expert opinion on drug delivery 21 (5) (2024)
Benjamin Rolland, Catriona Matheson, Ari Kaski, Margaux Kosim, Carlos Roncero, Florence Vorspan
Compared implementation of the long-acting buprenorphine treatment buvidal in four European countries. Expert opinion on drug delivery 21 (5) (2024)
Ketan Ranch, Disha Chawnani, Harshilkumar Jani, Devarshi Acharya, Chirag Amrutlal Patel, Shery Jacob, R Jayachandra Babu, Amit K Tiwari, Moawia M Al-Tabakha, Sai H S Boddu
An update on the latest strategies in retinal drug delivery. Expert opinion on drug delivery 21 (5) (2024)
Daniela Iannazzo, Salvatore V Giofrè, Claudia Espro, Consuelo Celesti
Graphene-based materials as nanoplatforms for antiviral therapy and prophylaxis. Expert opinion on drug delivery 21 (5) (2024)
Shize Li, Wenhao Zhang, Yuhao Zhu, Qing Yao, Ruijie Chen, Longfa Kou, Xulai Shi
Nanomedicine revolutionizes epilepsy treatment: overcoming therapeutic hurdles with nanoscale solutions. Expert opinion on drug delivery 21 (5) (2024)
Syed Ali Faran, Tanveer Hussain, Syed Haroon Khalid, Ikram Ullah Khan, Muhammad Asif, Junaid Ahmad, Abdul Rehman, Sajid Asghar
Bile acid/fatty acid integrated nanoemulsomes for nonalcoholic fatty liver targeted lovastatin delivery: stability, in-vitro, ex-vivo , and in-vivo analyses. Expert opinion on drug delivery 21 (5) (2024)
Laurie Brunet-Manquat, Anne Combedazou, Bomby Ahuja, Alice Maden, Claire Ramus, Tatsiana Mardovina, Cécile Frolet
Pre-ANDA strategy and Human Factors activities to de-risk pharmaceutical companies ANDA submission of drug-device combination products: case study of a formative Comparative Use Human Factors study. Expert opinion on drug delivery 21 (5) (2024)
Neeraj Vij
Precision nanoparticles for prognosis-based early intervention of COPD-emphysema. Expert opinion on drug delivery 21 (5) (2024)
Ketan Ranch, Disha Chawnani, Harshilkumar Jani, Devarshi Acharya, Chirag Amrutlal Patel, Shery Jacob, R Jayachandra Babu, Amit K Tiwari, Moawia M Al-Tabakha, Sai H S Boddu
An update on the latest strategies in retinal drug delivery. Expert opinion on drug delivery 21 (5) (2024)
Kristiina M Huttunen
Improving drug delivery to the brain: the prodrug approach. Expert opinion on drug delivery 21 (5) (2024)
Benjamin Rolland, Catriona Matheson, Ari Kaski, Margaux Kosim, Carlos Roncero, Florence Vorspan
Compared implementation of the long-acting buprenorphine treatment buvidal in four European countries. Expert opinion on drug delivery 21 (5) (2024)
Iordana Neamtu, Alina Ghilan, Alina Gabriela Rusu, Loredana Elena Nita, Vlad Mihai Chiriac, Aurica P Chiriac
Design and applications of polymer-like peptides in biomedical nanogels. Expert opinion on drug delivery 21 (5) (2024)
Benoit Hosten, Sébastien Goutal, Sarah Leterrier, Cassandre Corvo, Louise Breuil, Olivier Barret, Simon Specklin, Charles Truillet, Nicolas Tournier
Brain delivery enabled by transient blood-brain barrier disruption induced by regadenoson: a PET imaging study. Expert opinion on drug delivery 21 (5) (2024)
Syed Ali Faran, Tanveer Hussain, Syed Haroon Khalid, Ikram Ullah Khan, Muhammad Asif, Junaid Ahmad, Abdul Rehman, Sajid Asghar
Bile acid/fatty acid integrated nanoemulsomes for nonalcoholic fatty liver targeted lovastatin delivery: stability, in-vitro, ex-vivo , and in-vivo analyses. Expert opinion on drug delivery 21 (5) (2024)
Daniela Iannazzo, Salvatore V Giofrè, Claudia Espro, Consuelo Celesti
Graphene-based materials as nanoplatforms for antiviral therapy and prophylaxis. Expert opinion on drug delivery 21 (5) (2024)
Shize Li, Wenhao Zhang, Yuhao Zhu, Qing Yao, Ruijie Chen, Longfa Kou, Xulai Shi
Nanomedicine revolutionizes epilepsy treatment: overcoming therapeutic hurdles with nanoscale solutions. Expert opinion on drug delivery 21 (5) (2024)

volume 21, number 6, 2024

Yuxin He, Yifan Wang, Lin Wang, Wen Jiang, Stefan Wilhelm
Understanding nanoparticle-liver interactions in nanomedicine. Expert opinion on drug delivery 21 (6) (2024)
Yuxin He, Yifan Wang, Lin Wang, Wen Jiang, Stefan Wilhelm
Understanding nanoparticle-liver interactions in nanomedicine. Expert opinion on drug delivery 21 (6) (2024)
Jinghang Cong, Ziyang Zheng, Yanping Fu, Ziyao Chang, Chuangxin Chen, Chuanbin Wu, Xin Pan, Zhengwei Huang, Guilan Quan
Spatiotemporal fate of nanocarriers-embedded dissolving microneedles: the impact of needle dissolving rate. Expert opinion on drug delivery 21 (6) (2024)
Zhutian Zhang, Qian Ma, Zhaoxing Dai, Jiaxu Hong, Jifeng Gu, Rong Shi, Jianjiang Xu, Yaling Ma, Xinghuai Sun, Jianguo Sun
Sustained release of brimonidine from conjunctival sac insert to reduce intraocular pressure for glaucoma treatment. Expert opinion on drug delivery 21 (6) (2024)
Haohan Zhou, Yiyun Cheng, Quan Huang, Jianru Xiao
Regulation of ferroptosis by nanotechnology for enhanced cancer immunotherapy. Expert opinion on drug delivery 21 (6) (2024)
David Begley, Reinhard Gabathuler, Gregory Pastores, Angeles Garcia-Cazorla, Diego Ardigò, Maurizio Scarpa, Rosella Tomanin, Giovanni Tosi
Challenges and opportunities in neurometabolic disease treatment with enzyme delivery. Expert opinion on drug delivery 21 (6) (2024)
Kazunori Kadota, Hiromasa Uchiyama, Tero Kämäräinen, Shunsuke Tanaka, Yuichi Tozuka
Building respirable powder architectures: utilizing polysaccharides for precise control of particle morphology for enhanced pulmonary drug delivery. Expert opinion on drug delivery 21 (6) (2024)
Yuxin He, Yifan Wang, Lin Wang, Wen Jiang, Stefan Wilhelm
Understanding nanoparticle-liver interactions in nanomedicine. Expert opinion on drug delivery 21 (6) (2024)
Fan Liu, Yibin Deng, Anru Wang, Tao Yang, Hengte Ke, Yongan Tang, Hong Wu, Huabing Chen
Harness arsenic in medicine: current status of arsenicals and recent advances in drug delivery. Expert opinion on drug delivery 21 (6) (2024)
Kosheli Thapa Magar, Hamza Boucetta, Zongmin Zhao, Ying Xu, Zhengxia Liu, Wei He
Injectable long-acting formulations (ILAFs) and manufacturing techniques. Expert opinion on drug delivery 21 (6) (2024)
Olavi Reinsalu, Mart Ernits, Veikko Linko
Liposome-based hybrid drug delivery systems with DNA nanostructures and metallic nanoparticles. Expert opinion on drug delivery 21 (6) (2024)
Adrianna Zygmunt, Jerzy Gubernator
Metabolism and structure of PDA as the target for new therapies: possibilities and limitations for nanotechnology. Expert opinion on drug delivery 21 (6) (2024)

volume 21, number 7, 2024

Preksha Vinchhi, Wong Tin Wui, Mayur M Patel
Healing with herbs: an alliance with 'nano' for wound management. Expert opinion on drug delivery 21 (7) (2024)
Tanisha Tabassum Sayka Khan, Zara Sheikh, Simin Maleknia, Farshad Oveissi, Ali Fathi, Terence Abrams, Hui Xin Ong, Daniela Traini
Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges. Expert opinion on drug delivery 21 (7) (2024)
Tuba Bedir, Sachin Kadian, Shubhangi Shukla, Oguzhan Gunduz, Roger Narayan
Additive manufacturing of microneedles for sensing and drug delivery. Expert opinion on drug delivery 21 (7) (2024)
Stefania Glieca, Eride Quarta, Benedetta Bottari, Vivek C Lal, Fabio Sonvico, Francesca Buttini
The role of airways microbiota on local and systemic diseases: a rationale for probiotics delivery to the respiratory tract. Expert opinion on drug delivery 21 (7) (2024)
Oly Katari, Keshav Kumar, Shrushti Bhamble, Sanyog Jain
Gemini surfactants as next-generation drug carriers in cancer management. Expert opinion on drug delivery 21 (7) (2024)
Arzu Ari, Jordan A Hoops, Ayfer Koyuncu, James B Fink
Dos and don'ts to optimize transnasal aerosol drug delivery in clinical practice. Expert opinion on drug delivery 21 (7) (2024)
Bruna Silva, Eduardo F Marques, Andreia Castro Gomes
Recent advances in in vitro models simulating the female genital tract toward more effective intravaginal therapeutic delivery. Expert opinion on drug delivery 21 (7) (2024)
Muhammad Waseem Akram, Tin Wui Wong
Translational hurdles in anti-asthmatic nanomedicine development. Expert opinion on drug delivery 21 (7) (2024)
Pauline H M Janssen, Sara Fathollahi, Bastiaan H J Dickhoff, Henderik W Frijlink
Critical review on the role of excipient properties in pharmaceutical powder-to-tablet continuous manufacturing. Expert opinion on drug delivery 21 (7) (2024)
Minglong Chen, Yue Zhou, Yanping Fu, Qingqing Wang, Chuanbin Wu, Xin Pan, Guilan Quan
Biomaterials-assisted cancer vaccine delivery: preclinical landscape, challenges, and opportunities. Expert opinion on drug delivery 21 (7) (2024)